Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Debacker, A
Small-molecule drugs are subject to Abbreviated New Drug Application (ANDA) pathways for generic approval, which require demonstration of bioequivalence but not repeat clinical trials
This is pro-safety, pro-science, and pro-public health
For some, Ive been using them for years, and Ive even written more detailed reviews (Ill add the links in my products descriptions)
Emerging strategies of nanomaterial-mediated tumor radiosensitization
US$ 24.53
US$ 28.10
US$ 28.24
